Publications

Export 155 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: First Letter Of Title is C  [Clear All Filters]
A B [C] D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
C
Jansen MA, Badlou BA, van Echteld CJ, Ruigrok TJ. Cytosolic Ca2+ concentration during Ca2+ depletion of isolated rat hearts. Mol Cell Biochem. 2000;203(1-2):169-75. Abstract
Davidson L, Pawson AJ, Millar RP, Maudsley S. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem. 2004;279(3):1980-93. Abstract
Concha C, Morin V, Bustos P, Genevière AM, Heck MM, Puchi M, et al. Cysteine-protease involved in male chromatin remodeling after fertilization co-localizes with alpha-tubulin at mitosis. J Cell Physiol. 2005;202(2):602-7. Abstract
Martin C, Bean R, Rose K, Habib F, Seckl J. cyp7b1 catalyses the 7alpha-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate. The Biochemical journal. 2001;355:509-15. Abstract
Martin C, Ross M, Chapman KE, Andrew R, Bollina P, Seckl JR, et al. CYP7B generates a selective estrogen receptor beta agonist in human prostate. The Journal of clinical endocrinology and metabolism. 2004;89:2928-35. Abstract
Davies E, Kenyon CJ. CYP11B2 polymorphisms and cardiovascular risk factors. Journal of hypertension. 2003;21:1249-53.
Mullins LJ, Peter A, Wrobel N, McNeilly JR, McNeilly AS, Al-Dujaili EA, et al. Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. The Journal of biological chemistry. 2009;284:3925-34. Abstract
Opay AL, Mouton CR, Mullins JJ, Mitchell KD. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol. 2006;291(3):F612-8. Abstract
Shaw CA, Webb DJ, Rossi AG, Megson IL. Cyclic GMP protects human macrophages against peroxynitrite-induced apoptosis. Journal of inflammation (London, England). 2009;6:14. Abstract
Mullins LJ, Mullins J. Current successes and limitations of using genetic modification for blood pressure research. Pflügers Archiv : European journal of physiology. 2003;445:491-4.
Macleod M. Current issues in the treatment of acute posterior circulation stroke. CNS drugs. 2006;20:611-21. Abstract
Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JR, Mullins LJ, et al. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic acids research. 2007;35:1402-10. Abstract
Rintoul RC, Buttery RC, Mackinnon AC, Wong WS, Mosher D, Haslett C, et al. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Molecular biology of the cell. 2002;13:2841-52. Abstract
Rintoul RC, Buttery RC, Mackinnon AC, Wong WS, Mosher D, Haslett C, et al. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell. 2002;13(8):2841-52. Abstract
Maxwell SR, Webb DJ. COX-2 selective inhibitors–important lessons learned. Lancet. 2005;365:449-51.
Fox KA. COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart. 2009;95(9):689-92.
Fox KA. COURAGE or FAME...? Who should have percutaneous coronary intervention in stable coronary artery disease? Heart. 2012.
Fox KA. COURAGE or FAME...? Who should have percutaneous coronary intervention in stable coronary artery disease? Heart. 2012.
Hammer M, Lammert M, Mejías SM, Kern W, Frier BM. Costs of managing severe hypoglycaemia in three European countries. J Med Econ. 2009;12(4):281-90. Abstract
Epstein DM, Sculpher MJ, Clayton TC, Henderson RA, Pocock SJ, Buxton MJ, et al. Costs of an early intervention versus a conservative strategy in acute coronary syndrome. International journal of cardiology. 2008;127:240-6. Abstract
Thokala P, Goodacre SW, Collinson PO, Stevens JW, Mills NL, Newby DE, et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart. 2012;98(20):1498-503. Abstract
Schwenkglenks M, Brazier JE, Szucs TD, Fox KA. Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. Value Health. 2011;14(1):24-33. Abstract
Henriksson M, Epstein DM, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, et al. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart (British Cardiac Society). 2008;94:717-23. Abstract
Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R, et al. Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcified tissue international. 2005;77:134-8. Abstract
Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC, et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes. 2009;58:46-53. Abstract